Показано 0 из 0
|
|
|
|
Tvardi Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need.
| 04.03.2024 |
|
| 13.11.2023 |
|
| 07.08.2023 |
|
| 15.05.2023 |
|